Thu, March 24, 2011
[ Thu, Mar 24th 2011 ] - Market Wire
Gilead fija precio de obligaciones senior no garantizadas por valor de $1.000 millones
[ Thu, Mar 24th 2011 ] - Market Wire
Adamis Reports APC-300 Kills Human Pancreatic Cancer Cells
[ Thu, Mar 24th 2011 ] - Market Wire
CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings
[ Thu, Mar 24th 2011 ] - Market Wire
Baxter International Inc. First Quarter 2011 Financial Results Conference Call
[ Thu, Mar 24th 2011 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Lidocaine HCl Jelly, 2%
[ Thu, Mar 24th 2011 ] - Market Wire
Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck
[ Thu, Mar 24th 2011 ] - Market Wire
Abiomed to Host PROTECT II Investor Meeting at ACC 2011
[ Thu, Mar 24th 2011 ] - Market Wire
Geron to Webcast Analyst and Investor Meeting on Companya?s Oncology Programs on March 29, 2011
[ Thu, Mar 24th 2011 ] - Market Wire
West and CareFusion Announce Plans to Develop an Innovative Needle-Free Vented Vial Access Device
[ Thu, Mar 24th 2011 ] - Market Wire
Healthcare Acquisition Activity on the Rise as Key Patents Run Out
[ Thu, Mar 24th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Completes Patient E .. nical Trial Investigating REOLYSIN® in Combi
[ Thu, Mar 24th 2011 ] - Market Wire
Unigenea?s Oral Peptide Drug Delivery Technology .. ine Phase 3 Results from Tarsaa?s ORACAL Trial of
[ Thu, Mar 24th 2011 ] - Market Wire
Fase III klinische trial van Gileads onderzoeksge .. et aan primaire doelstelling voor eerste 48 weken
Wed, March 23, 2011
[ Wed, Mar 23rd 2011 ] - Market Wire
AdCare Health Systems Reports Record Fourth Quarter and Full Year 2010 Results
[ Wed, Mar 23rd 2011 ] - Market Wire
Affymax and Takeda to Present Additional Peginesa .. Patients at the National Kidney Foundation (NKF)
[ Wed, Mar 23rd 2011 ] - Market Wire
El ensayo clnico de Fase III del frmaco en fase d .. itegravir, supera el objetivo principal de 48 sem
[ Wed, Mar 23rd 2011 ] - Market Wire
A.M. Best Withdraws Ratings of Priority Health Ca .. nc. and Peninsula Health Care, Inc. Due to Merger
[ Wed, Mar 23rd 2011 ] - Market Wire
Mesa Uranium Files 43-101 Report, Expands the Green Energy Project
[ Wed, Mar 23rd 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems' Medical Advisory Members
[ Wed, Mar 23rd 2011 ] - Market Wire
Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting
[ Wed, Mar 23rd 2011 ] - Market Wire
Phase III Clinical Trial of Gileada?s Investigational Elvitegravir Meets 48-Week Primary Objective
[ Wed, Mar 23rd 2011 ] - Market Wire
Prana Biotechnology Limited Raises A$6.12 Million in a Private Placement
[ Wed, Mar 23rd 2011 ] - Market Wire
POZEN Announces Licensing Deal with Cilag GmbH, A .. Johnson & Johnson, for MT 400, Migraine Treatment
[ Wed, Mar 23rd 2011 ] - Market Wire
Nordion announces Phase III clinical trial to eva .. or liver metastases in colorectal cancer patients
[ Wed, Mar 23rd 2011 ] - Market Wire
CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction
[ Wed, Mar 23rd 2011 ] - Market Wire
Announcement of the Execution of a License Agreement for Unoprostone
Tue, March 22, 2011
[ Tue, Mar 22nd 2011 ] - Market Wire
New Acetadote® Formulation Now Available in the U.S.
[ Tue, Mar 22nd 2011 ] - Market Wire
Amyris aumenta sua capacidade de produo atrav©s de acordo com a Paraso Bioenergia
[ Tue, Mar 22nd 2011 ] - Market Wire
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinic .. Academy of Allergy, Asthma and Immunology (AAAAI)
[ Tue, Mar 22nd 2011 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup
[ Tue, Mar 22nd 2011 ] - Market Wire
LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO
[ Tue, Mar 22nd 2011 ] - Market Wire
Radient Pharmaceuticals Receives Additional Deficiency Notice From NYSE Amex
[ Tue, Mar 22nd 2011 ] - Market Wire
InSite Vision Announces Positive Phase 1/2 Result .. on of Pain and Inflammation after Cataract Surger
[ Tue, Mar 22nd 2011 ] - Market Wire
POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation
[ Tue, Mar 22nd 2011 ] - Market Wire
Amyris Adds Additional Production Capacity Through Agreement With Paraso Bioenergia
[ Tue, Mar 22nd 2011 ] - Market Wire
Pro-Pharmaceuticals Expands Patent Portfolio with New Patents in the U.S. and Australia
[ Tue, Mar 22nd 2011 ] - Market Wire
Emergent BioSolutions to Present at Needham & Company Healthcare Conference
[ Tue, Mar 22nd 2011 ] - Market Wire
Schiff Nutrition International, Inc. Announces Fiscal 2011 Third Quarter Results
[ Tue, Mar 22nd 2011 ] - Market Wire
Given Imaging to Present at the 10th Annual Needham Healthcare Conference
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ] - Market Wire
2010 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
[ Mon, Mar 21st 2011 ] - Market Wire
U.S. Physical Therapy to Present at the Sidoti Fi .. nual Emerging Growth Institutional Investor Forum
[ Mon, Mar 21st 2011 ] - Market Wire
Covidien Announces Interim Data Showing Parietex .. Significantly Reduces Early Pain Following Inguin
[ Mon, Mar 21st 2011 ] - Market Wire
30 p.m. ET
[ Mon, Mar 21st 2011 ] - Market Wire
Anacor Pharmaceuticals Secures $30 Million Loan Facility
[ Mon, Mar 21st 2011 ] - Market Wire
RXi Pharmaceuticals Presents New Preclinical RNAi .. one Mechanism and Biology of Silencing Conference
[ Mon, Mar 21st 2011 ] - Market Wire
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA
[ Mon, Mar 21st 2011 ] - Market Wire
Amyris and U.S. Venture Announce Plans for Joint Venture in Development of Renewable Lubricants
[ Mon, Mar 21st 2011 ] - Market Wire
Biotech Sector Is a Hotbed of Takeover Speculation
[ Mon, Mar 21st 2011 ] - Market Wire
Teleflex Announces Retirement of 2004 Senior Notes
[ Mon, Mar 21st 2011 ] - Market Wire
Given Imaging Wins Patent Infringement Lawsuit in Germany
[ Mon, Mar 21st 2011 ] - Market Wire
XenoPort Reports Results from a Phase 2b Clinical .. il as Adjunctive Treatment for Patients with GERD
[ Mon, Mar 21st 2011 ] - Market Wire
Santarus and Pharming Announce RHUCIN Poster at A .. Allergy, Asthma & Immunology 2011 Annual Meeting
Sun, March 20, 2011
[ Sun, Mar 20th 2011 ] - Market Wire
Curis Announces Positive Results in Genentech Piv .. rial of GDC-0449 in Advanced Basal Cell Carcinoma
Fri, March 18, 2011
[ Fri, Mar 18th 2011 ] - Market Wire
Parere positivo del Comitato per i prodotti medic .. i per uso umano sul nuovo contraccettivo NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
Forest Laboratories Announces Expiration of Hart- .. o Waiting Period for Acquisition of Clinical Data
[ Fri, Mar 18th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Therag
[ Fri, Mar 18th 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems .. paring for Clinical Trials; Will Prioritize Heart
[ Fri, Mar 18th 2011 ] - Market Wire
Comit© voor geneesmiddelen voor menselijk gebrui .. deelt positief over nieuwe anticonceptie NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB
[ Fri, Mar 18th 2011 ] - Market Wire
Rotech Healthcare Inc. Announces Closing of Priva .. Offering of $290 Million Senior Second Lien Notes
[ Fri, Mar 18th 2011 ] - Market Wire
Committee for Medicinal Products for Human Use (C .. Opinion for New Contraception Offering, NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
Teva Receives Positive Opinion for NOMAC/E2 from the European Committee for Medicinal Products
[ Fri, Mar 18th 2011 ] - Market Wire
Affymax Announces Pricing of Public Offering of Common Stock
[ Fri, Mar 18th 2011 ] - Market Wire
Algoma Central Corporation Announces Increase to Bought Deal Financing
[ Fri, Mar 18th 2011 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. yosin Activation Published in the Journal Science
[ Fri, Mar 18th 2011 ] - Market Wire
Declarao da Covidien sobre o impacto do terremoto japons
Thu, March 17, 2011
[ Thu, Mar 17th 2011 ] - Market Wire
Covidien Statement on the Impact of the Japanese Earthquake
[ Thu, Mar 17th 2011 ] - Market Wire
HearUSA Responds to Siemens Filing
[ Thu, Mar 17th 2011 ] - Market Wire
SunCoast RHIO Joins Connect HIN - Florida Health Information Network (FLHIN)
[ Thu, Mar 17th 2011 ] - Market Wire
CPEX Pharmaceuticals Advises Stockholders to Take .. Response to Mangrove Partnersa? Revised Proposal
[ Thu, Mar 17th 2011 ] - Market Wire
Antrim Energy Inc. Announces Closing of Financing
[ Thu, Mar 17th 2011 ] - Market Wire
CytRx Begins Phase 1b Clinical Trial with INNO-206 in Patients with Advanced Solid Tumors
[ Thu, Mar 17th 2011 ] - Market Wire
Radient Pharmaceuticals Hires DLA Piper to Defend Company Against Class Action Lawsuit
[ Thu, Mar 17th 2011 ] - Market Wire
Self Funding Administrators Corporation Joins American CareSource's Growing Client Portfolio
[ Thu, Mar 17th 2011 ] - Market Wire
ImmuCell Announces Sales and Marketing Collaboration With AgriLabs
[ Thu, Mar 17th 2011 ] - Market Wire
Prime Equity Research Initiates Independent Coverage On Fresh Start
[ Thu, Mar 17th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Announces 2010 Year End Results
[ Thu, Mar 17th 2011 ] - Market Wire
Alnylam Responds to Tekmira Complaint
[ Thu, Mar 17th 2011 ] - Market Wire
AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011
Wed, March 16, 2011
[ Wed, Mar 16th 2011 ] - Market Wire
CEO da Covidien deixar o cargo em 1 de julho. Seu Sucessor j foi Nomeado
[ Wed, Mar 16th 2011 ] - Market Wire
El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien elige como presidente y director ejecutivo a Jose E. Almeida
[ Wed, Mar 16th 2011 ] - Market Wire
St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant
[ Wed, Mar 16th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER
[ Wed, Mar 16th 2011 ] - Market Wire
Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien Elects Jose E. Almeida President and Chief Executive Officer
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien CEO to Retire July 1; Successor Named
[ Wed, Mar 16th 2011 ] - Market Wire
Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt
[ Wed, Mar 16th 2011 ] - Market Wire
CEO di Covidien in pensione dal 1 luglio - nominato successore
[ Wed, Mar 16th 2011 ] - Market Wire
TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES
[ Wed, Mar 16th 2011 ] - Market Wire
Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders
[ Wed, Mar 16th 2011 ] - Market Wire
AlphaRx Provides Corporate and Development Update
Tue, March 15, 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien bepaalt contant kwartaaldividend en maak .. n van jaarlijkse algemene vergadering 2011 bekend
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien setzt vierteljhrliche Bardividende fest .. ibt Ergebnisse der Jahresversammlung 2011 bekannt
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien d©clare un dividende trimestriel en esp .. les r©sultats de son assembl©e g©n©rale 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock
[ Tue, Mar 15th 2011 ] - Market Wire
Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution
[ Tue, Mar 15th 2011 ] - Market Wire
Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration
[ Tue, Mar 15th 2011 ] - Market Wire
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women
[ Tue, Mar 15th 2011 ] - Market Wire
Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents
[ Tue, Mar 15th 2011 ] - Market Wire
Merck to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 15th 2011 ] - Market Wire
Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Illumina Prices $800 Million Convertible Senior Notes
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
[ Mon, Mar 14th 2011 ] - Market Wire
Teva to Present at the Barclays Capital 2011 Global Healthcare Conference
[ Mon, Mar 14th 2011 ] - Market Wire
Health Net, Inc. Investigating Unaccounted-for Server Drives
[ Mon, Mar 14th 2011 ] - Market Wire
30 AM E.T.
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta
[ Mon, Mar 14th 2011 ] - Market Wire
HemaCare Reports Fourth Quarter and Year End Results
[ Mon, Mar 14th 2011 ] - Market Wire
Medtronic Announces Global Launch of New Heart Va .. Ring Designed to Adapt to Hearta?s Natural Valve
[ Mon, Mar 14th 2011 ] - Market Wire
Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Announces Conference Call to Discuss Pha .. cal Trial Results of RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Covidien Announces New Data on Hernia and Abdomin .. ir Products to Be Presented at Hernia Repair 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Human Genome Sciences Appoints George Morrow to its Board of Directors
Sun, March 13, 2011
[ Sun, Mar 13th 2011 ] - Market Wire
DaVita Enhances Already Strong Governance Policies
Sat, March 12, 2011
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead raccomanda di rifiutare la?offerta di minigara presentata da TRC Capital Corporation
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead empfiehlt Ablehnung von Mini-bernahmeangebot durch TRC Capital Corporation
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead Adviseert Afwijzing van Mini-Overnamebod door TRC Capital Corporation
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ] - Market Wire
The Rosen Law Firm Files Class Action Lawsuit Cha .. ceuticals Corporation With Securities Fraud - RPC
[ Fri, Mar 11th 2011 ] - Market Wire
Edwards Lifesciences Acquires Embrella Cardiovascular, Inc.
[ Fri, Mar 11th 2011 ] - Market Wire
Aetna Recognized by the National Business Group on Health for Reducing Disparities in Care
[ Fri, Mar 11th 2011 ] - Market Wire
Orthofix Sports Medicine Launches Three New Products in March
[ Fri, Mar 11th 2011 ] - Market Wire
Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference
[ Fri, Mar 11th 2011 ] - Market Wire
NovaDel Pharma Inc. to Present at ROTH 23rd Annual OC Growth Stock Conference
[ Fri, Mar 11th 2011 ] - Market Wire
Human Genome Sciences oraz GlaxoSmithKline oglasz .. DA na wprowadzenie na rynek BENLYSTA® (Belimumab
[ Fri, Mar 11th 2011 ] - Market Wire
Equity Research on Elan Corp. plc and Valeant Pha .. Drug Delivery Sector Sees Opportunities and Growi
[ Fri, Mar 11th 2011 ] - Market Wire
CytRx Reports 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Synta Announces Clinical Program Updates and 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Human Genome Sciences????????????BENLYSTA® (?????) ?FDA??????????????
[ Fri, Mar 11th 2011 ] - Market Wire
Centric Health Reports Solid 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
[ Thu, Mar 10th 2011 ] - Market Wire
Covidien recibe la autorizacin de la FDA para los .. basados en uranio de bajo enriquecimiento produci
[ Thu, Mar 10th 2011 ] - Market Wire
Covidien obtient la?approbation de la FDA pour un .. rique du Sud bas© sur de la?uranium faiblement e
[ Thu, Mar 10th 2011 ] - Market Wire
A Brighter Decade Ahead for Biotech - In-Depth Re .. ch Featuring Biodel Inc. and MannKind Corporation
[ Thu, Mar 10th 2011 ] - Market Wire
Anacor Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
[ Thu, Mar 10th 2011 ] - Market Wire
CompCare Expands Management Team to Drive Continued Innovation and Bottom-Line Growth
[ Thu, Mar 10th 2011 ] - Market Wire
Northstar Healthcare Reports 2010 Results
[ Thu, Mar 10th 2011 ] - Market Wire
Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
[ Thu, Mar 10th 2011 ] - Market Wire
Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences e GlaxoSmithKline annuncian .. zione da parte dell'FDA per il BENLYSTA® (belimu
[ Thu, Mar 10th 2011 ] - Market Wire
Santarus Initiates Phase I Clinical Study with SAN-300
[ Thu, Mar 10th 2011 ] - Market Wire
BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences und GlaxoSmithKline melden .. (Belimumab) zur Behandlung von systemischem Lupus
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences et GlaxoSmithKline annoncen .. ur BENLYSTA® (Belimumab) dans le traitement du l
Wed, March 9, 2011
[ Wed, Mar 09th 2011 ] - Market Wire
The Law Offices of Vincent Wong Announce an Inves .. hes of Fiduciary Duty by the Board of TomoTherapy
[ Wed, Mar 09th 2011 ] - Market Wire
A.M. Best Revises Outlook to Stable for Coventry Health Care, Inc. and Its Subsidiaries
[ Wed, Mar 09th 2011 ] - Market Wire
Renegade Petroleum Ltd. Announces Closing of $41.9 Million Bought Deal Financing
[ Wed, Mar 09th 2011 ] - Market Wire
Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs
[ Wed, Mar 09th 2011 ] - Market Wire
Fight Colorectal Cancer and Genomic Health Launch Unique Online Resource for Colon Cancer Patients
[ Wed, Mar 09th 2011 ] - Market Wire
Avid Bioservices to Present Comparability Studies .. ge-Scale Manufacturing of Clinical-Stage Antibody
[ Wed, Mar 09th 2011 ] - Market Wire
Corcept Therapeutics Announces Fourth Quarter Results and Corporate and Development Update
[ Wed, Mar 09th 2011 ] - Market Wire
Biotech's Response to the MRSA Epidemic
[ Wed, Mar 09th 2011 ] - Market Wire
DUSA Pharmaceuticals to Present at Roth Capital Partners 23rd Annual OC Growth Stock Conference
[ Wed, Mar 09th 2011 ] - Market Wire
Opexa Therapeutics Reports Year End 2010 Financial Results and Provides Corporate Update
[ Wed, Mar 09th 2011 ] - Market Wire
Biomagnetics to Receive Funding From BIOTECH Deve .. pment Partners for Commercialization of Biosensor
[ Wed, Mar 09th 2011 ] - Market Wire
Hythiam to Present at the Roth 23rd Annual OC Growth Stock Conference
[ Wed, Mar 09th 2011 ] - Market Wire
Lilly CEO Calls for Biopharmaceutical Industry Ch .. es and Policies That Encourage Medical Innovation
Tue, March 8, 2011
[ Tue, Mar 08th 2011 ] - Market Wire
Medtronic CareLink® Network Remote Monitoring He .. Improve Patient Care and Reduce Healthcare Costs
[ Tue, Mar 08th 2011 ] - Market Wire
Derma Sciences to Present at the Roth Capital Partners Growth Stock Conference
[ Tue, Mar 08th 2011 ] - Market Wire
China Kanghui Holdings Announces Participation in Upcoming Investor Events
[ Tue, Mar 08th 2011 ] - Market Wire
Arrowhead Research to Present at the Roth Capital .. 3rd Annual OC Growth Stock Conference on March 16
[ Tue, Mar 08th 2011 ] - Market Wire
ZIOPHARM to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Yellowhead Mining Reports Positive Results of Preliminary Economic Assessment
[ Tue, Mar 08th 2011 ] - Market Wire
Marina Biotech, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Dynavax Reports Fourth Quarter and Year End 2010 Financial Results
[ Tue, Mar 08th 2011 ] - Market Wire
Applied DNA Sciences, Inc. Migrates to the OTCQB Tier of the OTC Marketplace
[ Tue, Mar 08th 2011 ] - Market Wire
Cytori Patents Method of Making Stem and Regenerative Cell-Enriched Fat Grafts
[ Tue, Mar 08th 2011 ] - Market Wire
Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial
[ Tue, Mar 08th 2011 ] - Market Wire
GTSO JV Secures NewRare Earth Mining Lease in Mongolia
[ Tue, Mar 08th 2011 ] - Market Wire
Healthways Announces Planned Transition of President, Stefen Brueckner, to Senior Advisor Role
Mon, March 7, 2011
[ Mon, Mar 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of TomoTherapy Incorporated, in Connection wit
[ Mon, Mar 07th 2011 ] - Market Wire
Prana to Present at Cowen and Company Health Care Conference
[ Mon, Mar 07th 2011 ] - Market Wire
TomoTherapy Incorporated Shareholder Investigatio .. m Concerning Sale to Accuray Incorporated a" TOMO
[ Mon, Mar 07th 2011 ] - Market Wire
Kendall Law Group Investigates TomoTherapy Inc. Acquisition for Shareholders
[ Mon, Mar 07th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Investigates Buyout of TomoTherapy Incorporated - TOMO
[ Mon, Mar 07th 2011 ] - Market Wire
Stellar's Common Shares Now Trading on OTCQB
[ Mon, Mar 07th 2011 ] - Market Wire
Daxor Announces Publication of Research Article D .. 100 Data to Guide Shock Resuscitation Led to Sign
[ Mon, Mar 07th 2011 ] - Market Wire
Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results
[ Mon, Mar 07th 2011 ] - Market Wire
Allied Healthcare International Inc. Acquires ScotHomecare
[ Mon, Mar 07th 2011 ] - Market Wire
Amedisys to Present at the Raymond James and Asso .. es 32nd Annual Institutional Investors Conference
[ Mon, Mar 07th 2011 ] - Market Wire
Rotech Healthcare Inc. Announces Proposed Private .. Offering of $290 Million Senior Second Lien Notes
[ Mon, Mar 07th 2011 ] - Market Wire
Compugen Announces Positive Animal Model Results .. de Predicted to Block Protein-Protein Interaction
[ Mon, Mar 07th 2011 ] - Market Wire
ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia
Sat, March 5, 2011
[ Sat, Mar 05th 2011 ] - Market Wire
Harper Creek Drill Hole HC10-82 Confirms Minerali .. thern Limit of Drill Holes in 2010 Resource Model
Fri, March 4, 2011
[ Fri, Mar 04th 2011 ] - Market Wire
Teva to Present at the Cowen and Company 31st Annual Health Care Conference
[ Fri, Mar 04th 2011 ] - Market Wire
DaVita Is Recognized for Clinical and Operational Excellence Early in 2011
[ Fri, Mar 04th 2011 ] - Market Wire
U.S. FDA Removes Warning about Potential Liver In .. of Prescribing Information for Gilead's Letairis
[ Fri, Mar 04th 2011 ] - Market Wire
Lannett Comments on News Article
[ Fri, Mar 04th 2011 ] - Market Wire
Paul Hennessey Named VP Operations at Prestige Brands
[ Fri, Mar 04th 2011 ] - Market Wire
CPEX Receives Letter from Athyrium Capital Management
[ Fri, Mar 04th 2011 ] - Market Wire
Helix BioPharma Corp. Announces Fiscal Q2 2011 Results
[ Fri, Mar 04th 2011 ] - Market Wire
Given Imaging Goes Blue for Colorectal Cancer Awareness Month
[ Fri, Mar 04th 2011 ] - Market Wire
BURCON ENTERS LICENSE AGREEMENT WITH ADM FOR CLARISOY® PROTEIN TECHNOLOGY
[ Fri, Mar 04th 2011 ] - Market Wire
America Service Group, Inc. Shareholder Investiga .. erning Acquisition by Valitas Health Services, In
[ Fri, Mar 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of America Service Group Inc., in Connection w
[ Fri, Mar 04th 2011 ] - Market Wire
Court Ruling Clears Way for Jury Trial in $1 Billion Texas Medicaid Whistleblower Lawsuit

Vertex Announces Webcast of its Presentation at the Barclays Capital 2011 Global Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. s-capital-2011-global-healthcare-conference.html
Published in Health and Fitness on Monday, March 14th 2011 at 13:20 GMT by Market Wire   Print publication without navigation


CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentation at the Barclays Capital 2011 Healthcare Conference on Wednesday, March 16, 2011 at 2:00 p.m. EDT.

The presentation will be webcast live and may be accessed from aEvents & Presentationsa™ on the home page of Vertexa™s website at [ www.vrtx.com ]. A replay of the webcast will also be available on the Companya™s website for two weeks following the presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex creates new possibilities in medicine. Our team aims to discover, develop and commercialize innovative therapies so people with serious diseases can lead better lives.

Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, epilepsy and other life-threatening diseases.

Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada.

Vertexa™s press releases are available at [ www.vrtx.com ].

(VRTX-WEB)


Publication Contributing Sources